234 related articles for article (PubMed ID: 29949146)
1. HOTTIP regulates progression of endometrial cancer via activating PI3K/AKT pathway.
Guan Q; Zhang Q; Zhang C; Liu Q; Ren QL
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3727-3733. PubMed ID: 29949146
[TBL] [Abstract][Full Text] [Related]
2. HOTTIP participates in mammary cancer by promoting cell proliferation via PI3K/AKT pathway.
Gao W; Wu XL; Li DZ; Liu HD
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4181-4187. PubMed ID: 30024606
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA HOTAIR Promotes Endometrial Carcinoma Cell Proliferation by Binding to PTEN via the Activating Phosphatidylinositol 3-Kinase/Akt Signaling Pathway.
Zhang XH; Hu P; Xie YQ; Kang YJ; Li M
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31527078
[TBL] [Abstract][Full Text] [Related]
5. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
Guo X; Liu Y; Zheng X; Han Y; Cheng J
Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
[TBL] [Abstract][Full Text] [Related]
6. LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.
Zhang Z; Liu X; Xu H; Li P; Zeng T; Du W; Lu X
J BUON; 2018; 23(6):1745-1752. PubMed ID: 30610803
[TBL] [Abstract][Full Text] [Related]
7. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
Zhu L; Wang X; Wang T; Zhu W; Zhou X
Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway.
Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
10. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
[TBL] [Abstract][Full Text] [Related]
11. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA LINC01224 promotes cell proliferation and inhibits apoptosis by regulating AKT3 expression via targeting miR‑485‑5p in endometrial carcinoma.
Zuo X; Li W; Yan X; Ma T; Ren Y; Hua M; Yang H; Wu H; Zhu H
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278482
[TBL] [Abstract][Full Text] [Related]
14. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
Lei Y; Wang YH; Wang XF; Bai J
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6315-6323. PubMed ID: 30338799
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4.
Wang L; Zhao S; Mingxin YU
Pharmazie; 2019 May; 74(5):295-300. PubMed ID: 31109400
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
[TBL] [Abstract][Full Text] [Related]
17. NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer.
Fan Y; Dong Z; Shi Y; Sun S; Wei B; Zhan L
J Int Med Res; 2020 May; 48(5):300060520925352. PubMed ID: 32431202
[TBL] [Abstract][Full Text] [Related]
18. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
19. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
20. HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.
Yun WK; Hu YM; Zhao CB; Yu DY; Tang JB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2786-2793. PubMed ID: 31002129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]